Shire said it is willing to recommend that shareholders accept Takeda Pharmaceutical’s last-ditch $64 billion takeover bid and extended the deadline for a possible deal.
WSJ.com: What's News Asia, Wall Street Journal: What's News Asia
Tue, 04/24/2018 - 8:47pm
Shire said it is willing to recommend that shareholders accept Takeda Pharmaceutical’s last-ditch $64 billion takeover bid and extended the deadline for a possible deal.